News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

BIOQuebec Release: Conference On Mergers And Acquisitions In The Biopharmaceutical Industry By Aventis Pharma AG (AVE) President - October 21st In Montreal


10/19/2005 5:11:50 PM

MONTREAL, Oct. 14 /PRNewswire/ -- BIOQuebec, an association representing companies in the biotech and health sciences sectors in Quebec, will be hosting a luncheon conference presented by the President of Aventis Pharma, Mr. Jean-Francois Leprince. The lunch-time conference will take place next Thursday, October 21, at the Omni Hotel in Montreal.

In his presentation, Mr. Leprince will be elaborating on internal and external factors that lead to mergers and acquisitions in the pharmaceutical industry. Participants will get first-hand information, as Aventis was acquired by Sanofi-Sythelabo in 2004.

Proudly representing its more than 250 members, BIOQuebec is one the most important networks for bio-industry and health sciences in Canada.

Members of the media are requested to confirm their presence by contacting Ani Armenian, Director of Communications, at (514) 733-8411, extension 207.

BIOQUEBEC

CONTACT: Ani Armenian, Director of communications, BIOQuebec,(514) 733-8411, extension 207; or please visit the Web site athttp://www.bioquebec.com/


Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES